TD Cowen Reiterates Buy on Surgery Partners, Maintains $19 Price Target

TD Cowen analyst Ryan Langston has reiterated a Buy rating on Surgery Partners (NASDAQ: SGRY) and has maintained a price target of $19 for the stock.